Burhol P G, Jenssen T G, Lygren I, Schulz T B, Jorde R, Waldum H L
Digestion. 1982;23(3):156-68. doi: 10.1159/000198723.
The preparation of a stable fully immunoreactive 125I-labeled CCK39 using a modified Iodo-gen method with high specific radioactivity; the production of an avid and specific cholecystokinin (CCK) antiserum, and a sensitive, precise and specific radioimmunoassay method allowing measurements of fasting plasma CCK in the low picomole per liter range together with the significant rises in plasma CCK following a test meal and duodenal infusion of fat are described. Apparent immunoreactive fasting plasma CCK was eluted from a Sephadex G-50 Fine column in one peak probably representing plasma CCK bound to plasma proteins and nonspecific plasma effects. Apparent immunoreactive postprandial plasma CCK was eluted from a Sephadex G-50 Fine column in four peaks. The first peak probably represents plasma CCK bound to plasma proteins and nonspecific plasma effects; the second peak probably represents component I with a molecular weight between some 5,000 and 30,000; the third peak probably represents component II or CCK33, and the fourth peak probably represents component IV or CCK8.
采用改良的碘代法制备具有高比放射性的稳定的完全免疫反应性125I标记的CCK39;制备高效且特异的胆囊收缩素(CCK)抗血清,以及一种灵敏、精确且特异的放射免疫分析方法,该方法能够测量低皮摩尔每升范围内的空腹血浆CCK,同时还能检测试餐后和十二指肠输注脂肪后血浆CCK的显著升高。明显具有免疫反应性的空腹血浆CCK从Sephadex G - 50 Fine柱上以一个峰洗脱下来,该峰可能代表与血浆蛋白结合的血浆CCK和非特异性血浆效应。明显具有免疫反应性的餐后血浆CCK从Sephadex G - 50 Fine柱上以四个峰洗脱下来。第一个峰可能代表与血浆蛋白结合的血浆CCK和非特异性血浆效应;第二个峰可能代表分子量在约5000至30000之间的组分I;第三个峰可能代表组分II或CCK33,第四个峰可能代表组分IV或CCK8。